Predicted to enable chromatin binding activity and chromatin-protein adaptor activity. Predicted to contribute to DNA clamp loader activity. Predicted to be involved in several processes, including mitotic DNA integrity checkpoint signaling; negative regulation of DNA replication; and protein localization to site of double-strand break. Predicted to act upstream of or within DNA damage response. Predicted to be located in chromosome, telomeric region; nucleolus; and nucleoplasm. Predicted to be part of Rad17 RFC-like complex. Predicted to be active in site of double-strand break. Orthologous to human RAD17 (RAD17 checkpoint clamp loader component).
RGD Description
Predicted to enable chromatin binding activity and chromatin-protein adaptor activity. Predicted to contribute to DNA clamp loader activity. Predicted to be involved in several processes, including mitotic DNA integrity checkpoint signaling; negative regulation of DNA replication; and protein localization to site of double-strand break. Predicted to act upstream of or within DNA damage response. Predicted to be located in chromosome, telomeric region; nucleolus; and nucleoplasm. Predicted to be part of Rad17 RFC-like complex. Predicted to be active in site of double-strand break. Orthologous to human RAD17 (RAD17 checkpoint clamp loader component); INTERACTS WITH (+)-schisandrin B; 2,3,7,8-Tetrachlorodibenzofuran; 2,4-dinitrotoluene.